SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041062-22-000034
Filing Date
2022-02-08
Accepted
2022-02-08 12:44:32
Documents
1
Group Members
BRANDES INVESTMENT PARTNERS, L.P.BRANDES WORLDWIDE HOLDINGS, L.P.CO-GP, LLCGLENN CARLSON

Document Format Files

Seq Description Document Type Size
1 Avadel_Pharmaceuticals.txt SC 13G/A 11594
  Complete submission text file 0001041062-22-000034.txt   13597
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 22600157
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

IRS No.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A